In this study, we investigated the cellular mechanisms by which DV, a bioactive ECM fragment released after stroke [14] leads to VEGF secretion and eventually to its neuroprotective and pro-angiogenic effects [14], as schematized in Figure 6. This evidence concerns the gene VEGFA and Stroke.